Cell Isolation Market/ Cell Separation Market by Product [Consumables (Media, Beads), Instrument (Centrifuges, Filtration)], Cell Type (Stem Cell), Source, Technique, Application (IVD, Research, CGT), End User, Competition, Region - Global Forecast to 2031

icon1
USD 7.97 BN
MARKET SIZE, 2031
icon2
CAGR 12.7%
(2026-2031)
icon3
470
REPORT PAGES
icon4
630
MARKET TABLES

CELL ISOLATION MARKET SIZE, SHARE & GROWTH SNAPSHOT

cell-isolation-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global cell isolation market is projected to grow from USD 4.39 billion in 2026 to USD 7.97 billion by 2031, at a CAGR of 12.7% during the forecast period. The market was valued at USD 4.18 billion in 2025. The growth of the cell isolation market is driven by the increasing adoption of advanced cell separation technologies, along with rising demand for immune cell isolation, single-cell analysis, cell and gene therapy development, and translational research applications. Expanding use of cell isolation in drug discovery, clinical diagnostics, cancer research, stem cell research, and regenerative medicine is accelerating the adoption of cell separation workflows across research and clinical settings. Additionally, the growing focus on obtaining high-purity, viable, and application-specific cell populations is boosting demand for advanced instruments, magnetic beads, isolation kits, density gradient media, disposables, and automated cell processing solutions across the market.

KEY TAKEAWAYS

  • By Region
    North America accounted for the largest share, at 43%, of the cell isolation market in 2025. The growth in this region is driven by strong biopharmaceutical and biotechnology R&D activity, advanced healthcare and research infrastructure, high investments in cell and gene therapy development, and the presence of leading market players promoting the adoption of advanced cell separation technologies.
  • By Product
    By product, consumables accounted for the largest share, at 65%, of the cell isolation market in 2025. This dominance is driven by the frequent use of cell isolation reagents & kits, tissue dissociation reagents, media, sera, magnetic and fluorescent beads, and disposables across cell separation, enrichment, purification, and downstream analysis workflows.
  • By Technique
    By technique, centrifugation-based cell isolation accounted for the largest share of the cell isolation market in 2025. This is attributed to its widespread use as a cost-effective, routine, and scalable method for separating cells based on size, density, and sedimentation properties across research, clinical, and bioprocessing workflows.
  • By End User
    By end user, pharmaceutical & biotechnology companies accounted for the largest share of the cell isolation market in 2025. This dominance is driven by increasing R&D investments, growing use of isolated cells in drug discovery and development, expanding cell and gene therapy pipelines, and rising adoption of high-purity cell populations for translational research and therapeutic applications.
  • Competitive Landscape
    Danaher (US), Merck KGaA (Germany), and Thermo Fisher Scientific Inc. (US) were identified as key players in the cell isolation market, given their strong market share and product portfolios.
  • Competitive Landscape
    MagBio Genomics, Inc., Akadeum Life Sciences, and pluriSelect Life Science UG (haftungsbeschränkt) & Co. KG, among others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.

The cell isolation market is growing due to the increasing adoption of advanced mass spectrometry and immunoassay technologies, rising focus on precision medicine and biomarker research, expanding use of cell isolation in clinical diagnostics and drug discovery, and continuous advancements in high-throughput protein analysis and cell isolation data interpretation.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The cell isolation market is shifting from conventional manual separation methods toward advanced, automated, closed, and high-throughput cell separation platforms to improve purity, viability, and workflow reproducibility. Adoption of magnetic-activated cell separation, fluorescence-activated cell sorting, microfluidics, and label-free isolation technologies is increasing, enabling precise enrichment of immune cells, stem cells, circulating tumor cells, and primary cells from complex biological samples. Additionally, the growing demand for scalable, low-contamination, and GMP-compatible cell isolation workflows supported by automation, single-use consumables, and standardized isolation kits is accelerating market growth. Furthermore, enhanced cell recovery, reduced manual variability, faster sample processing, and broader integration with downstream applications such as single-cell analysis, cell therapy manufacturing, drug discovery, and clinical diagnostics are driving advances in this market.

cell-isolation-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Expansion of cell and gene therapy workflows
  • Rising demand for immune cell isolation
RESTRAINTS
Impact
Level
  • High cost of instruments and consumables
  • Loss of cell viability and recovery during isolation
OPPORTUNITIES
Impact
Level
  • Growing demand for GMP-grade cell isolation products
  • Adoption of microfluidic and label-free isolation technologies
CHALLENGES
Impact
Level
  • Balancing purity, yield, viability, and cost
  • Scaling research workflows to GMP manufacturing

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Expansion of cell and gene therapy workflows

The expansion of cell and gene therapy workflows is significantly strengthening the cell isolation market by increasing the need for high-purity, viable, and functionally intact cell populations. Cell isolation is a critical step in workflows involving T cells, NK cells, stem cells, hematopoietic cells, and other therapeutic cell types used in research, process development, and clinical manufacturing. As cell therapy developers move from early-stage research to clinical and commercial-scale manufacturing, demand is increasing for automated, closed, and GMP-compatible isolation systems, magnetic beads, separation kits, and single-use consumables that support reproducibility, sterility, and scalability.

Restraint: High cost of instruments and consumables

The high cost of cell isolation instruments and consumables remains a major restraint for the market. Advanced cell sorters, automated magnetic separation systems, closed cell processing platforms, and microfluidic isolation systems require significant capital investment, along with ongoing costs for maintenance, calibration, software, service contracts, and trained personnel. In addition, recurring expenditure on magnetic beads, antibody-based kits, density gradient media, single-use disposables, and GMP-grade reagents increases the overall cost per sample or batch. This creates barriers to adoption for small laboratories, academic institutes, and cost-sensitive clinical or research facilities.

Opportunity: Growing demand for GMP-grade cell isolation products

The growing demand for GMP-grade cell isolation products presents a strong opportunity for the cell isolation market as clinical and manufacturing workflows increasingly require validated, sterile, and reproducible products. Cell and gene therapy developers need isolation reagents, magnetic beads, buffers, single-use kits, and closed processing systems that can support regulatory expectations and minimize contamination risk. This is particularly important for immune cell isolation, stem cell enrichment, and therapeutic cell processing, where product quality, cell viability, and consistency directly affect downstream performance. Suppliers offering scalable, GMP-compliant, and workflow-integrated solutions are well-positioned to benefit from this demand.

Challenge: Balancing purity, yield, viability, and cost

Balancing purity, yield, viability, and cost remains a key challenge in the cell isolation market. Highly selective isolation methods can improve purity but may reduce cell recovery, increase processing time, or affect cell viability, especially when working with fragile primary cells, rare cell populations, or limited clinical samples. Similarly, automated and closed systems can improve reproducibility and contamination control but may increase workflow costs. End users must optimize isolation protocols based on application needs, whether for research, diagnostics, single-cell analysis, or cell therapy manufacturing. Achieving consistent results while maintaining affordability and scalability remains a major challenge across workflows.

CELL ISOLATION MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Sepax C-Pro and Sefia systems applied in automated, functionally closed cell isolation and processing workflows for cell therapy development and commercialization Closed-system cell processing | Reduced contamination risk | Improved workflow reproducibility | Supports clinical-scale cell therapy manufacturing
Gibco CTS Dynabeads and CTS DynaCellect Magnetic Separation System applied in T-cell isolation, activation, and bead removal workflows for cell therapy development and manufacturing Scalable immune cell isolation | Improved T-cell activation workflow | GMP-ready cell therapy processing | Reduced manual handling

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The cell isolation market ecosystem comprises raw material suppliers, product providers, end users, and regulatory authorities. Raw material suppliers, including Bio-Techne, Actylis, and PELO Biotech, support the market by providing critical inputs such as antibodies, enzymes, media components, buffers, sera, beads, and other materials used in the development of cell isolation products. Product providers such as Thermo Fisher Scientific, Sony Biotechnology, Merck, and Danaher supply instruments, reagents, kits, beads, media, disposables, and automated platforms used across cell separation, enrichment, purification, and downstream processing workflows. Regulatory authorities, including the US FDA, CDSCO, OLAW, MHRA, ANVISA, and Health Canada, establish requirements for product quality, safety, validation, sterility, and compliance, particularly for clinical research and cell therapy manufacturing applications. End users, including Amgen, Novartis, Merck, MIT, and other biopharmaceutical companies, research institutes, clinical laboratories, and cell therapy developers, utilize cell isolation solutions for drug discovery, immunology research, cancer biology, stem cell research, regenerative medicine, clinical diagnostics, and cell and gene therapy workflows.

cell-isolation-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

cell-isolation-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Cell Isolation Market, By Product

In 2025, the consumables segment dominated the cell isolation market. This leadership is driven by the recurring use of cell isolation reagents & kits, tissue dissociation reagents, media, sera, magnetic beads, fluorescent beads, buffers, and disposables across cell separation and enrichment workflows. These products are widely used in immune cell isolation, stem cell research, primary cell isolation, clinical diagnostics, drug discovery, and cell therapy development. The need for high-purity, viable, and reproducible cell populations continues to support steady demand for consumables across research and clinical settings.

Cell Isolation Market, By Cell Type

In 2025, the human cells segment dominated the cell isolation market, supported by the growing use of human-derived immune cells, stem cells, leukocytes, circulating tumor cells, and differentiated cells in drug discovery, translational research, clinical diagnostics, and cell and gene therapy development. Human cells are widely used for disease modeling, biomarker discovery, immunology studies, cancer research, and personalized medicine applications. The increasing adoption of single-cell analysis and GMP-compatible cell processing further strengthens the demand for human cell isolation products.

Cell Isolation Market, By End User

In 2025, pharmaceutical & biotechnology companies dominated the cell isolation market due to their strong focus on R&D, drug discovery, immuno-oncology, regenerative medicine, and cell and gene therapy development. These companies widely use cell isolation technologies to obtain purified and viable cell populations for target validation, mechanism-of-action studies, biomarker analysis, preclinical research, and therapeutic manufacturing workflows. Rising investment in advanced cell-based research and increasing demand for scalable, automated, and reproducible cell isolation solutions are driving demand across this end-user group.

CELL ISOLATION MARKET: COMPANY EVALUATION MATRIX

In the cell isolation market company evaluation matrix, Danaher Corporation is positioned as a star player due to its strong presence across cell separation, flow cytometry, and automated cell processing workflows. Through Cytiva and Beckman Coulter Life Sciences, the company offers a broad range of cell sorters, flow cytometry platforms, automated cell processing systems, closed-system cell isolation solutions, and workflow-enabling consumables used in research, clinical, and cell therapy applications. Its global reach, comprehensive portfolio, strong installed base, and consistent focus on automation, scalability, and GMP-compatible workflows make it a preferred partner for pharmaceutical, biotechnology, academic, and clinical research organizations. Sony Corporation is considered an emerging leader in this market. The company is strengthening its position through advanced flow cytometry and cell-sorting platforms that enable high-purity cell isolation, immune profiling, single-cell analysis, and translational research workflows. Its focus on compact, high-performance cell-sorting technologies and on expanding application relevance across immunology, oncology, and cell-based research is driving increased adoption, thereby strengthening its market position.

cell-isolation-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2025 (Value) USD 4.18 Billion
Market Forecast in 2026 (Value) USD 4.39 Billion
Market Forecast in 2031 (Value) USD 7.97 Billion
Growth Rate CAGR of 12.7% from 2026-2031
Years Considered 2024-2031
Base Year 2025
Forecast Period 2026-2031
Units Considered Value (USD Billion)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Product:
    • Consumables
    • Instruments
  • By Cell Type:
    • Human Cells
    • Animal Cells
  • By Cell Source:
    • Blood & Blood-derived Samples
    • Adipose Tissue
    • Bone Marrow
    • Cord Blood/Embryonic Stem Cells
    • Other Cell Sources
  • By Technique:
    • Centrifugation-based Cell Isolation
    • Surface Marker-based Cell Isolation
    • Filtration-based Cell Isolation
    • Microfluidics and Label-free Cell Isolation
  • By Application:
    • Research Applications
    • Drug Discovery and Development
    • In Vitro Diagnostics
    • CGT Manufacturing
  • By End User:
    • Pharmaceutical & Biotechnology Companies
    • Academic & Research Institutes
    • Hospitals & Diagnostic Laboratories
    • Other End Users
Regions Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

WHAT IS IN IT FOR YOU: CELL ISOLATION MARKET REPORT CONTENT GUIDE

cell-isolation-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Rest of Europe Breakdown Country-level market sizing and growth forecasts (Switzerland, Sweden, Turkey, the Netherlands, Norway, Poland, Portugal, Romania, Denmark, Estonia, Finland, the Czech Republic, Greece, Austria, Belgium, and Russia) Provides granular country-level insights, enabling clients to prioritize high-growth markets
Company Evaluation
  • Detailed analysis and profiling of top five market players
  • Portfolio assessment of top five companies
 Delivers visibility into competitors, helping clients identify partners, evaluate positioning, and detect market gaps for smarter collaboration, outsourcing, and strategic market entry decisions

RECENT DEVELOPMENTS

  • March 2026 : Danaher and SR-TIGET launched a collaboration, Danaher Beacon, to advance next-generation genomic medicine platforms. The initiative focuses on lentiviral gene transfer and targeted gene editing of hematopoietic stem cells, with an emphasis on automating cell manipulation and improving processes across cell and gene therapy workflows.
  • October 2025 : Alfa Laval launched the Culturefuge 200 B separator for medium-scale high-density fermentation harvesting. The system uses Hermetic Design and Bactofuge technology for gentle, continuous separation and is designed for cell harvesting, microbial cell separation, cell debris separation, probiotic separation, and suspended protein separation.
  • January 2025 : Merck acquired HUB Organoids to expand its next-generation biology and 3D cell culture portfolio. The acquisition added organoid model generation, assay development, and high-throughput screening capabilities, strengthening Merck’s cell culture and cell-based drug discovery offerings.

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
 
 
46
2
EXECUTIVE SUMMARY
 
 
 
 
 
51
3
PREMIUM INSIGHTS
 
 
 
 
 
56
4
MARKET OVERVIEW
Explore transformative shifts driving cell isolation market growth and innovation opportunities.
 
 
 
 
 
59
 
4.1
INTRODUCTION
 
 
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
 
 
 
4.2.1.1
EXPANSION OF CELL AND GENE THERAPY WORKFLOWS
 
 
 
 
 
 
4.2.1.2
RISING DEMAND FOR IMMUNE CELL ISOLATION
 
 
 
 
 
 
4.2.1.3
GROWING ADOPTION OF SINGLE-CELL ANALYSIS
 
 
 
 
 
 
4.2.1.4
SHIFT TOWARD AUTOMATED AND CLOSED ISOLATION SYSTEMS
 
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
 
 
 
4.2.2.1
HIGH COST OF INSTRUMENTS AND CONSUMABLES
 
 
 
 
 
 
4.2.2.2
LOSS OF CELL VIABILITY AND RECOVERY DURING ISOLATION
 
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
 
 
 
4.2.3.1
GROWING DEMAND FOR GMP-GRADE CELL ISOLATION PRODUCTS
 
 
 
 
 
 
4.2.3.2
ADOPTION OF MICROFLUIDIC AND LABEL-FREE ISOLATION TECHNOLOGIES
 
 
 
 
 
4.2.4
CHALLENGES
 
 
 
 
 
 
 
4.2.4.1
SCALING RESEARCH WORKFLOWS TO GMP MANUFACTURING
 
 
 
 
 
 
4.2.4.2
BALANCING PURITY, YIELD, VIABILITY, AND COST
 
 
 
 
4.3
UNMET NEEDS & WHITE SPACES
 
 
 
 
 
 
4.4
INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
 
4.5
STRATEGIC MOVIES BY TIER-1/2/3 PLAYERS
 
 
 
 
 
5
INDUSTRY TRENDS
Navigate competitive forces shaping biotech and healthcare markets with strategic insights on pricing and trade.
 
 
 
 
 
68
 
5.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
 
5.1.1
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
 
 
 
5.1.2
BARGAINING POWER OF SUPPLIERS
 
 
 
 
 
 
5.1.3
BARGAINING POWER OF BUYERS
 
 
 
 
 
 
5.1.4
THREAT OF SUBSTITUTES
 
 
 
 
 
 
5.1.5
THREAT OF NEW ENTRANTS
 
 
 
 
 
5.2
MACROECONOMIC OUTLOOK
 
 
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
 
 
5.2.2
GDP TRENDS & FORECAST
 
 
 
 
 
 
5.2.3
TRENDS IN GLOBAL HEALTHCARE INDUSTRY
 
 
 
 
 
 
5.2.4
TRENDS IN GLOBAL BIOTECH INDUSTRY
 
 
 
 
 
5.3
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
 
5.4
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
 
 
5.4.1
ROLE OF PLAYERS IN ECOSYSTEM
 
 
 
 
 
5.5
PRICING ANALYSIS
 
 
 
 
 
 
 
 
5.5.1
AVERAGE SELLING PRICE TREND OF CELL ISOLATION INSTRUMENTS, BY TYPE, 2023–2025
 
 
 
 
 
 
5.5.2
AVERAGE SELLING PRICE TREND OF CELL ISOLATION CONSUMABLES, BY TYPE, 2023–2025
 
 
 
 
 
 
5.5.3
AVERAGE SELLING PRICE TREND OF CELL ISOLATION INSTRUMENTS, BY REGION, 2023–2025
 
 
 
 
 
 
5.5.4
AVERAGE SELLING PRICE TREND OF CELL ISOLATION CONSUMABLES, BY REGION, 2023–2025
 
 
 
 
 
5.6
TRADE ANALYSIS
 
 
 
 
 
 
 
 
5.6.1
IMPORT SCENARIO (HS CODE 3822.00)
 
 
 
 
 
 
5.6.2
EXPORT SCENARIO (HS CODE 3822.00)
 
 
 
 
 
5.7
KEY CONFERENCES & EVENTS, 2026–2027
 
 
 
 
 
 
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
 
 
 
 
 
 
5.9
INVESTMENT & FUNDING SCENARIO
 
 
 
 
 
 
 
5.10
CASE STUDY ANALYSIS
 
 
 
 
 
 
 
5.10.1
MICROFLUIDIC CELL SORTING IMPROVES CAR-T STARTING MATERIAL QUALITY
 
 
 
 
 
 
5.10.2
CLOSED-SYSTEM CELL ENRICHMENT SUPPORTS NK CELL MANUFACTURING
 
 
 
 
 
 
5.10.3
MICROFLUIDIC ISOLATION ENHANCES CTC RECOVERY IN PANCREATIC CANCER
 
 
 
 
 
5.11
IMPACT OF 2025 US TARIFFS ON CELL ISOLATION MARKET
 
 
 
 
 
 
 
 
5.11.1
INTRODUCTION
 
 
 
 
 
 
5.11.2
KEY TARIFF RATES
 
 
 
 
 
 
5.11.3
PRICE IMPACT ANALYSIS
 
 
 
 
 
 
5.11.4
IMPACT ON COUNTRY/REGION
 
 
 
 
 
 
 
5.11.4.1
US
 
 
 
 
 
 
5.11.4.2
EUROPE
 
 
 
 
 
 
5.11.4.3
ASIA PACIFIC
 
 
 
 
 
5.11.5
IMPACT ON END-USE INDUSTRIES
 
 
 
 
 
 
 
5.11.5.1
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
 
 
 
 
 
 
5.11.5.2
ACADEMIC & RESEARCH INSTITUTES
 
 
 
 
 
 
5.11.5.3
HOSPITALS & DIAGNOSTIC LABORATORIES
 
 
 
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
AI-driven cell isolation technologies revolutionize market with innovative patents and transformative future applications.
 
 
 
 
 
90
 
6.1
TECHNOLOGY ANALYSIS
 
 
 
 
 
 
 
6.1.1
KEY TECHNOLOGIES
 
 
 
 
 
 
 
6.1.1.1
CENTRIFUGATION-BASED TECHNIQUES
 
 
 
 
 
 
6.1.1.2
MAGNETIC CELL ISOLATION
 
 
 
 
 
 
6.1.1.3
FLUORESCENCE-ACTIVATED CELL SORTING
 
 
 
 
 
 
6.1.1.4
ACOUSTOFLUIDIC CELL ISOLATION
 
 
 
 
 
 
6.1.1.5
FILTRATION & SIZE-BASED CELL ISOLATION
 
 
 
 
 
6.1.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
 
 
6.1.2.1
MASS CYTOMETRY
 
 
 
 
 
 
6.1.2.2
CELL IMAGING TECHNOLOGIES
 
 
 
 
 
 
6.1.2.3
AI-ENABLED IMAGE-BASED SORTING
 
 
 
 
 
6.1.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
 
 
6.1.3.1
SINGLE-CELL SEQUENCING
 
 
 
 
 
 
6.1.3.2
CRISPR & GENE EDITING
 
 
 
 
 
 
6.1.3.3
3D CELL CULTURE & ORGANOIDS
 
 
 
 
6.2
TECHNOLOGY ROADMAP
 
 
 
 
 
 
6.3
PATENT ANALYSIS
 
 
 
 
 
 
 
 
6.3.1
METHODOLOGY
 
 
 
 
 
 
6.3.2
NUMBER OF PATENTS FILED, BY DOCUMENT TYPE
 
 
 
 
 
 
6.3.3
LIST OF KEY PATENTS
 
 
 
 
 
6.4
FUTURE APPLICATIONS
 
 
 
 
 
 
6.5
IMPACT OF AI/GEN AI ON CELL ISOLATION MARKET
 
 
 
 
 
 
 
 
6.5.1
TOP USE CASES & MARKET POTENTIAL
 
 
 
 
 
 
6.5.2
BEST PRACTICES IN AI-ENABLED CELL ISOLATION WORKFLOWS
 
 
 
 
 
 
6.5.3
CASE STUDIES OF AI IMPLEMENTATION IN CELL ISOLATION MARKET
 
 
 
 
 
 
6.5.4
INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS
 
 
 
 
 
 
6.5.5
CLIENTS’ READINESS TO ADOPT AI-INTEGRATED CELL ISOLATION TECHNOLOGIES
 
 
 
 
7
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
Unlock strategic insights into buyer dynamics and unmet needs across diverse industries.
 
 
 
 
 
102
 
7.1
DECISION-MAKING PROCESS
 
 
 
 
 
 
7.2
BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
 
 
 
 
 
 
 
7.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
 
 
7.2.2
KEY BUYING CRITERIA, BY END USER
 
 
 
 
 
7.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
 
 
7.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
 
 
 
 
 
8
SUSTAINABILITY & REGULATORY LANDSCAPE
Navigate global sustainability with insights on regional regulations and compliance standards.
 
 
 
 
 
106
 
8.1
REGIONAL REGULATIONS & COMPLIANCE
 
 
 
 
 
 
 
8.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
8.1.2
INDUSTRY STANDARDS
 
 
 
 
 
 
 
8.1.2.1
NORTH AMERICA
 
 
 
 
 
 
8.1.2.2
EUROPE
 
 
 
 
 
 
8.1.2.3
ASIA PACIFIC
 
 
 
 
 
 
8.1.2.4
REST OF THE WORLD
 
 
 
 
8.2
SUSTAINABILITY INITIATIVES
 
 
 
 
 
 
8.3
IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
 
 
 
 
 
 
8.4
CERTIFICATIONS, LABELING, AND ECO-STANDARDS
 
 
 
 
 
9
CELL ISOLATION MARKET, BY PRODUCT
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 102 Data Tables
 
 
 
 
 
115
 
9.1
INTRODUCTION
 
 
 
 
 
 
9.2
CONSUMABLES
 
 
 
 
 
 
 
9.2.1
REAGENTS & KITS
 
 
 
 
 
 
 
9.2.1.1
CELL ISOLATION REAGENTS & KITS
 
 
 
 
 
 
 
 
9.2.1.1.1
EXPANSION OF DOWNSTREAM SINGLE-CELL GENOMICS TO DRIVE MARKET
 
 
 
 
9.2.1.2
TISSUE DISSOCIATION REAGENTS & KITS
 
 
 
 
 
 
 
 
9.2.1.2.1
INFLUX OF SOLID TUMOR ONCOLOGY PROFILING AND PRIMARY CELL CULTURE DERIVATIONS TO DRIVE GROWTH
 
 
 
 
9.2.1.3
OTHER REAGENTS & KITS
 
 
 
 
 
9.2.2
MEDIA & SERA
 
 
 
 
 
 
 
9.2.2.1
RISING FOCUS ON VIABLE, REPRODUCIBLE, AND CLINICALLY COMPATIBLE ISOLATED CELL WORKFLOWS TO FUEL MARKET
 
 
 
 
 
9.2.3
BEADS
 
 
 
 
 
 
 
9.2.3.1
GROWING DEMAND FOR BEADS IN T-CELL AND STEM CELL ISOLATION TO DRIVE MARKET GROWTH
 
 
 
 
 
9.2.4
DISPOSABLES
 
 
 
 
 
 
 
9.2.4.1
GROWING GOVERNMENT INVESTMENTS IN RESEARCH TO AID MARKET GROWTH
 
 
 
 
9.3
INSTRUMENTS
 
 
 
 
 
 
 
9.3.1
CENTRIFUGES
 
 
 
 
 
 
 
9.3.1.1
GROWING USE IN PHARMA-BIOTECH INDUSTRY TO BOOST MARKET
 
 
 
 
 
9.3.2
CELL SORTERS
 
 
 
 
 
 
 
9.3.2.1
RISE IN CELL-BASED RESEARCH INITIATIVES TO AUGMENT GROWTH
 
 
 
 
 
9.3.3
MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS
 
 
 
 
 
 
 
9.3.3.1
BOOMING USE IN RESEARCH FOR T-CELL AND STEM CELL ISOLATION TO DRIVE MARKET
 
 
 
 
 
9.3.4
FILTRATION SYSTEMS
 
 
 
 
 
 
 
9.3.4.1
RISING NEED TO ENSURE GOOD MANUFACTURING PRACTICE STANDARDS AND REGULATIONS TO BOOST MARKET
 
 
 
 
 
9.3.5
OTHER INSTRUMENTS
 
 
 
 
10
CELL ISOLATION MARKET, BY CELL TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 30 Data Tables
 
 
 
 
 
166
 
10.1
INTRODUCTION
 
 
 
 
 
 
10.2
HUMAN CELLS
 
 
 
 
 
 
 
10.2.1
DIFFERENTIATED CELLS
 
 
 
 
 
 
 
10.2.1.1
RISING USE OF MATURE HUMAN CELL POPULATIONS IN TRANSLATIONAL RESEARCH AND DRUG DEVELOPMENT TO FUEL GROWTH
 
 
 
 
 
10.2.2
STEM CELLS
 
 
 
 
 
 
 
10.2.2.1
RISE IN GRANTS AND FUNDING FOR STEM CELL RESEARCH TO DRIVE MARKET
 
 
 
 
10.3
ANIMAL CELLS
 
 
 
 
 
 
 
10.3.1
GROWING INVESTMENTS FOR VACCINE AND DRUG DEVELOPMENT TO SUPPORT GROWTH
 
 
 
 
11
CELL ISOLATION MARKET, BY CELL SOURCE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 36 Data Tables
 
 
 
 
 
182
 
11.1
INTRODUCTION
 
 
 
 
 
 
11.2
BLOOD & BLOOD-DERIVED SAMPLES
 
 
 
 
 
 
 
11.2.1
GROWING USE OF IMMUNE CELL ISOLATION FROM BLOOD-DERIVED SAMPLES TO DRIVE MARKET
 
 
 
 
 
11.3
ADIPOSE TISSUE
 
 
 
 
 
 
 
11.3.1
INCREASING APPLICATIONS IN CLINICAL STUDIES AND TRIALS TO DRIVE MARKET
 
 
 
 
 
11.4
BONE MARROW
 
 
 
 
 
 
 
11.4.1
GROWING DEMAND FOR TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS TO AID GROWTH
 
 
 
 
 
11.5
CORD BLOOD/EMBRYONIC STEM CELLS
 
 
 
 
 
 
 
11.5.1
GROWING USE OF STEM AND PROGENITOR CELL ISOLATION IN REGENERATIVE MEDICINE AND CELL THERAPY RESEARCH TO SUPPORT MARKET GROWTH
 
 
 
 
 
11.6
OTHER CELL SOURCES
 
 
 
 
 
12
CELL ISOLATION MARKET, BY TECHNIQUE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 29 Data Tables
 
 
 
 
 
201
 
12.1
INTRODUCTION
 
 
 
 
 
 
12.2
CENTRIFUGATION-BASED CELL ISOLATION
 
 
 
 
 
 
 
12.2.1
RISING DEMAND FOR SCALABLE, AUTOMATED, AND CLOSED CELL PREPARATION WORKFLOWS TO FUEL MARKET
 
 
 
 
 
12.3
SURFACE MARKER-BASED CELL ISOLATION
 
 
 
 
 
 
 
12.3.1
GROWING NEED FOR MARKER-SPECIFIC AND HIGH-PURITY CELL POPULATIONS TO PROPEL MARKET
 
 
 
 
 
12.4
FILTRATION-BASED CELL ISOLATION
 
 
 
 
 
 
 
12.4.1
NEED FOR AFFORDABLE FILTRATION TECHNIQUE TO DRIVE MARKET
 
 
 
 
 
12.5
MICROFLUIDICS & LABEL-FREE CELL ISOLATION
 
 
 
 
 
 
 
12.5.1
HIGH DEMAND FOR ONCOLOGY RESEARCH TO SUPPORT SEGMENTAL GROWTH
 
 
 
 
13
CELL ISOLATION MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 65 Data Tables
 
 
 
 
 
216
 
13.1
INTRODUCTION
 
 
 
 
 
 
13.2
RESEARCH APPLICATIONS
 
 
 
 
 
 
 
13.2.1
BIOMOLECULE ISOLATION
 
 
 
 
 
 
 
13.2.1.1
INCREASING DEMAND FOR BIOPHARMACEUTICAL PRODUCTS TO FUEL MARKET
 
 
 
 
 
13.2.2
CANCER RESEARCH
 
 
 
 
 
 
 
13.2.2.1
PRECISION ONCOLOGY AND RARE TUMOR CELL ANALYSIS TO DRIVE MARKET
 
 
 
 
 
13.2.3
STEM CELL RESEARCH
 
 
 
 
 
 
 
13.2.3.1
RISING GRANTS AND FUNDING FOR STEM CELL RESEARCH TO AUGMENT GROWTH
 
 
 
 
 
13.2.4
REGENERATIVE MEDICINE
 
 
 
 
 
 
 
13.2.4.1
EXPANDING STEM CELL AND TRANSLATIONAL THERAPY RESEARCH TO SUPPORT MARKET
 
 
 
 
 
13.2.5
OTHER RESEARCH APPLICATIONS
 
 
 
 
 
13.3
DRUG DISCOVERY & DEVELOPMENT
 
 
 
 
 
 
 
13.3.1
RISING ADOPTION OF CELL-BASED DRUG DISCOVERY AND PRECISION THERAPEUTICS TO PROPEL MARKET
 
 
 
 
 
13.4
IN VITRO DIAGNOSTICS
 
 
 
 
 
 
 
13.4.1
RISING ADOPTION OF LIQUID BIOPSY AND PRECISION DIAGNOSTICS TO PROPEL MARKET
 
 
 
 
 
13.5
CGT MANUFACTURING
 
 
 
 
 
 
 
13.5.1
EXPANSION OF GMP-COMPLIANT CGT MANUFACTURING CAPACITY TO PROPEL MARKET
 
 
 
 
14
CELL ISOLATION MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 29 Data Tables
 
 
 
 
 
250
 
14.1
INTRODUCTION
 
 
 
 
 
 
14.2
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
 
 
 
 
 
 
 
14.2.1
INCREASING INVESTMENTS BY KEY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO BOOST MARKET GROWTH
 
 
 
 
 
14.3
ACADEMIC & RESEARCH INSTITUTES
 
 
 
 
 
 
 
14.3.1
HIGH GOVERNMENT FUNDING FOR EDUCATIONAL PURPOSES TO FUEL SEGMENT
 
 
 
 
 
14.4
HOSPITALS & DIAGNOSTIC LABORATORIES
 
 
 
 
 
 
 
14.4.1
RISING DEMAND FOR ENRICHED CLINICAL CELL POPULATIONS IN ONCOLOGY AND HEMATOLOGY DIAGNOSTICS TO DRIVE MARKET
 
 
 
 
 
14.5
OTHER END USERS
 
 
 
 
 
15
CELL ISOLATION MARKET, BY REGION
Comprehensive coverage of 7 Regions with country-level deep-dive of 16 Countries | 315 Data Tables.
 
 
 
 
 
265
 
15.1
INTRODUCTION
 
 
 
 
 
 
15.2
NORTH AMERICA
 
 
 
 
 
 
 
15.2.1
US
 
 
 
 
 
 
 
15.2.1.1
STRONG BIOPHARMA R&D AND ADVANCED CELL SORTING ADOPTION TO DRIVE MARKET
 
 
 
 
 
15.2.2
CANADA
 
 
 
 
 
 
 
15.2.2.1
EXPANDING CELL THERAPY MANUFACTURING AND REGENERATIVE MEDICINE RESEARCH TO PROPEL MARKET
 
 
 
 
15.3
EUROPE
 
 
 
 
 
 
 
15.3.1
GERMANY
 
 
 
 
 
 
 
15.3.1.1
STRONG CELL & GENE THERAPY TRANSLATION AND GMP-READY AUTOMATED CELL PROCESSING TO AID MARKET GROWTH
 
 
 
 
 
15.3.2
UK
 
 
 
 
 
 
 
15.3.2.1
EXPANDING ADVANCED THERAPY INFRASTRUCTURE AND GMP-COMPATIBLE CELL PROCESSING WORKFLOWS TO DRIVE MARKET
 
 
 
 
 
15.3.3
FRANCE
 
 
 
 
 
 
 
15.3.3.1
EXPANDING BIOTHERAPY RESEARCH AND CELL & GENE THERAPY INFRASTRUCTURE TO DRIVE MARKET
 
 
 
 
 
15.3.4
ITALY
 
 
 
 
 
 
 
15.3.4.1
EXPANDING ADVANCED THERAPY TRIALS AND EX VIVO GENE THERAPY CAPABILITIES TO DRIVE MARKET
 
 
 
 
 
15.3.5
SPAIN
 
 
 
 
 
 
 
15.3.5.1
HOSPITAL-BASED CAR-T MANUFACTURING AND GMP-COMPATIBLE CELL PROCESSING WORKFLOWS TO AID GROWTH
 
 
 
 
 
15.3.6
REST OF EUROPE
 
 
 
 
 
15.4
ASIA PACIFIC
 
 
 
 
 
 
 
15.4.1
CHINA
 
 
 
 
 
 
 
15.4.1.1
EXPANDING CELL THERAPY PIPELINES AND REGENERATIVE MEDICINE COMMERCIALIZATION TO BOOST MARKET
 
 
 
 
 
15.4.2
JAPAN
 
 
 
 
 
 
 
15.4.2.1
IPSC RESEARCH LEADERSHIP, REGENERATIVE MEDICINE COMMERCIALIZATION, AND DOMESTIC CELL THERAPY MANUFACTURING EXPANSION TO DRIVE MARKET GROWTH
 
 
 
 
 
15.4.3
INDIA
 
 
 
 
 
 
 
15.4.3.1
BIOE3-LED BIOMANUFACTURING AND TRANSLATIONAL RESEARCH EXPANSION PROPEL MARKET
 
 
 
 
 
15.4.4
AUSTRALIA
 
 
 
 
 
 
 
15.4.4.1
HOSPITAL-LINKED GMP CELL THERAPY CAPACITY, REGENERATIVE MEDICINE TRIALS, AND TRANSLATIONAL RESEARCH INFRASTRUCTURE TO FUEL MARKET
 
 
 
 
 
15.4.5
SOUTH KOREA
 
 
 
 
 
 
 
15.4.5.1
BIOPROCESSING INFRASTRUCTURE EXPANSION AND REGENERATIVE MEDICINE FOCUS TO SUPPORT MARKET GROWTH
 
 
 
 
 
15.4.6
REST OF ASIA PACIFIC
 
 
 
 
 
15.5
LATIN AMERICA
 
 
 
 
 
 
 
15.5.1
BRAZIL
 
 
 
 
 
 
 
15.5.1.1
ADVANCED THERAPY REGULATION AND ONCOLOGY RESEARCH STRENGTH TO DRIVE MARKET
 
 
 
 
 
15.5.2
MEXICO
 
 
 
 
 
 
 
15.5.2.1
REGULATORY STRENGTHENING AND PHARMACEUTICAL INFRASTRUCTURE GROWTH TO SUPPORT THE MARKET
 
 
 
 
 
15.5.3
REST OF LATIN AMERICA
 
 
 
 
 
15.6
MIDDLE EAST
 
 
 
 
 
 
 
15.6.1
GCC COUNTRIES
 
 
 
 
 
 
 
15.6.1.1
SAUDI ARABIA
 
 
 
 
 
 
 
 
15.6.1.1.1
LOCAL ADVANCED THERAPY MANUFACTURING AND PRECISION MEDICINE INVESTMENT TO BOOST MARKET
 
 
 
 
15.6.1.2
UAE
 
 
 
 
 
 
 
 
15.6.1.2.1
STEM CELL RESEARCH INFRASTRUCTURE AND REGENERATIVE MEDICINE STANDARDS TO AID MARKET GROWTH
 
 
 
 
15.6.1.3
REST OF GCC COUNTRIES
 
 
 
 
 
15.6.2
REST OF MIDDLE EAST
 
 
 
 
 
15.7
AFRICA
 
 
 
 
 
 
 
15.7.1
POPULATION-SPECIFIC ONCOLOGY RESEARCH AND INFECTIOUS DISEASE STUDIES TO PROPEL MARKET
 
 
 
 
16
COMPETITIVE LANDSCAPE
Uncover strategic moves and market dominance of key players in the cell isolation industry.
 
 
 
 
 
409
 
16.1
OVERVIEW
 
 
 
 
 
 
16.2
KEY PLAYER STRATEGY/RIGHT TO WIN, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
 
16.2.1
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CELL ISOLATION MARKET, JANUARY 2023–APRIL 2026
 
 
 
 
 
16.3
REVENUE ANALYSIS, 2021–2025
 
 
 
 
 
 
 
16.4
MARKET SHARE ANALYSIS, 2025
 
 
 
 
 
 
 
16.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
 
 
 
 
 
 
 
 
16.5.1
STARS
 
 
 
 
 
 
16.5.2
EMERGING LEADERS
 
 
 
 
 
 
16.5.3
PERVASIVE PLAYERS
 
 
 
 
 
 
16.5.4
PARTICIPANTS
 
 
 
 
 
 
16.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2025
 
 
 
 
 
 
 
16.5.5.1
COMPANY FOOTPRINT
 
 
 
 
 
 
16.5.5.2
REGION FOOTPRINT
 
 
 
 
 
 
16.5.5.3
PRODUCT FOOTPRINT
 
 
 
 
 
 
16.5.5.4
CELL TYPE FOOTPRINT
 
 
 
 
 
 
16.5.5.5
END-USER FOOTPRINT
 
 
 
 
16.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
 
 
 
 
 
 
 
 
16.6.1
PROGRESSIVE COMPANIES
 
 
 
 
 
 
16.6.2
RESPONSIVE COMPANIES
 
 
 
 
 
 
16.6.3
DYNAMIC COMPANIES
 
 
 
 
 
 
16.6.4
STARTING BLOCKS
 
 
 
 
 
 
16.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
 
 
 
 
 
 
 
16.6.5.1
DETAILED LIST OF KEY STARTUP/SME PLAYERS
 
 
 
 
 
 
16.6.5.2
COMPETITIVE BENCHMARKING OF STARTUPS/SMES
 
 
 
 
16.7
COMPANY VALUATION & FINANCIAL METRICS
 
 
 
 
 
 
 
16.7.1
COMPANY VALUATION
 
 
 
 
 
 
16.7.2
FINANCIAL METRICS
 
 
 
 
 
16.8
BRAND/PRODUCT COMPARISON
 
 
 
 
 
 
 
16.9
COMPETITIVE SCENARIO
 
 
 
 
 
 
 
16.9.1
PRODUCT LAUNCHES
 
 
 
 
 
 
16.9.2
DEALS
 
 
 
 
 
 
16.9.3
EXPANSIONS
 
 
 
 
17
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
 
 
430
 
17.1
KEY PLAYERS
 
 
 
 
 
 
 
17.1.1
DANAHER CORPORATION
 
 
 
 
 
 
 
17.1.1.1
BUSINESS OVERVIEW
 
 
 
 
 
 
17.1.1.2
PRODUCTS OFFERED
 
 
 
 
 
 
17.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
 
 
 
 
17.1.1.3.1
DEALS
 
 
 
 
17.1.1.4
MNM VIEW
 
 
 
 
 
 
 
 
17.1.1.4.1
KEY STRENGTHS
 
 
 
 
 
 
17.1.1.4.2
STRATEGIC CHOICES
 
 
 
 
 
 
17.1.1.4.3
WEAKNESSES & COMPETITIVE THREATS
 
 
 
17.1.2
MERCK KGAA
 
 
 
 
 
 
17.1.3
THERMO FISHER SCIENTIFIC INC.
 
 
 
 
 
 
17.1.4
BECTON, DICKINSON AND COMPANY
 
 
 
 
 
 
17.1.5
AGILENT TECHNOLOGIES, INC.
 
 
 
 
 
 
17.1.6
SARTORIUS AG
 
 
 
 
 
 
17.1.7
BIO-RAD LABORATORIES, INC.
 
 
 
 
 
 
17.1.8
QIAGEN
 
 
 
 
 
 
17.1.9
F. HOFFMANN-LA ROCHE LTD.
 
 
 
 
 
 
17.1.10
REVVITY
 
 
 
 
 
 
17.1.11
CORNING INCORPORATED
 
 
 
 
 
 
17.1.12
LONZA
 
 
 
 
 
 
17.1.13
BIO-TECHNE
 
 
 
 
 
 
17.1.14
TERUMO CORPORATION
 
 
 
 
 
 
17.1.15
MILTENYI BIOTEC
 
 
 
 
 
 
17.1.16
TAKARA BIO INC.
 
 
 
 
 
 
17.1.17
GENSCRIPT
 
 
 
 
 
 
17.1.18
SONY CORPORATION
 
 
 
 
 
 
17.1.19
ALFA LAVAL
 
 
 
 
 
17.2
OTHER PLAYERS
 
 
 
 
 
 
 
17.2.1
PROMEGA CORPORATION
 
 
 
 
 
 
17.2.2
CELL SIGNALING TECHNOLOGY, INC.
 
 
 
 
 
 
17.2.3
MICAREO INC.
 
 
 
 
 
 
17.2.4
APPLIED CELLS, INC.
 
 
 
 
 
 
17.2.5
STEMCELL TECHNOLOGIES
 
 
 
 
 
 
17.2.6
CREATIVE BIOARRAY
 
 
 
 
 
 
17.2.7
PROTEINTECH GROUP, INC.
 
 
 
 
 
 
17.2.8
MAGBIO GENOMICS, INC.
 
 
 
 
 
 
17.2.9
AKADEUM LIFE SCIENCES
 
 
 
 
 
 
17.2.10
PLURISELECT LIFE SCIENCE UG (HAFTUNGSBESCHRÄNKT) & CO. KG
 
 
 
 
 
 
17.2.11
INVENT BIOTECHNOLOGIES, INC.
 
 
 
 
18
RESEARCH METHODOLOGY
 
 
 
 
 
505
 
18.1
RESEARCH DATA
 
 
 
 
 
 
 
18.1.1
SECONDARY DATA
 
 
 
 
 
 
 
18.1.1.1
KEY DATA FROM SECONDARY SOURCES
 
 
 
 
 
18.1.2
PRIMARY DATA
 
 
 
 
 
 
 
18.1.2.1
KEY DATA FROM PRIMARY SOURCES
 
 
 
 
 
 
18.1.2.2
KEY PRIMARY PARTICIPANTS
 
 
 
 
 
 
18.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
 
 
 
 
 
 
18.1.2.4
KEY INDUSTRY INSIGHTS
 
 
 
 
18.2
MARKET SIZE ESTIMATION
 
 
 
 
 
 
 
18.2.1
GLOBAL CELL ISOLATION MARKET ESTIMATION, 2025
 
 
 
 
 
 
18.2.2
SEGMENTAL MARKET SIZE ESTIMATION
 
 
 
 
 
18.3
MARKET GROWTH RATE PROJECTIONS
 
 
 
 
 
 
18.4
DATA TRIANGULATION
 
 
 
 
 
 
18.5
FACTOR ANALYSIS
 
 
 
 
 
 
18.6
RESEARCH ASSUMPTIONS
 
 
 
 
 
 
18.7
RESEARCH LIMITATIONS & RISK ASSESSMENT
 
 
 
 
 
19
APPENDIX
 
 
 
 
 
517
 
19.1
DISCUSSION GUIDE
 
 
 
 
 
 
19.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
 
 
19.3
CUSTOMIZATION OPTIONS
 
 
 
 
 
 
19.4
RELATED REPORTS
 
 
 
 
 
 
19.5
AUTHOR DETAILS
 
 
 
 
 
LIST OF TABLES
 
 
 
 
 
 
 
TABLE 1
CELL ISOLATION MARKET: INCLUSIONS & EXCLUSIONS
 
 
 
 
 
 
TABLE 2
CELL ISOLATION MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
 
 
 
 
 
 
TABLE 3
CELL ISOLATION MARKET: PORTER’S FIVE FORCES
 
 
 
 
 
 
TABLE 4
CELL ISOLATION MARKET: ROLE OF PLAYERS IN ECOSYSTEM
 
 
 
 
 
 
TABLE 5
AVERAGE SELLING PRICE TREND OF CELL ISOLATION INSTRUMENTS, BY TYPE, 2023–2025 (USD)
 
 
 
 
 
 
TABLE 6
AVERAGE SELLING PRICE TREND OF CELL ISOLATION CONSUMABLES, BY TYPE, 2023–2025 (USD)
 
 
 
 
 
 
TABLE 7
AVERAGE SELLING PRICE TREND OF CELL ISOLATION INSTRUMENTS, BY REGION, 2023–2025 (USD)
 
 
 
 
 
 
TABLE 8
AVERAGE SELLING PRICE TREND OF CELL ISOLATION CONSUMABLES, BY REGION, 2023–2025 (USD)
 
 
 
 
 
 
TABLE 9
IMPORT DATA FOR HS CODE 3822.00-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND)
 
 
 
 
 
 
TABLE 10
EXPORT DATA FOR HS CODE 3822.00-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND)
 
 
 
 
 
 
TABLE 11
CELL ISOLATION MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2026–MARCH 2027
 
 
 
 
 
 
TABLE 12
RECIPROCAL TARIFF RATES ADJUSTED BY US
 
 
 
 
 
 
TABLE 13
CRITICAL COMPONENTS LIKELY EXPOSED TO TARIFF CHANGES
 
 
 
 
 
 
TABLE 14
NUMBER OF PATENTS FILED, BY DOCUMENT TYPE, 2015–2025
 
 
 
 
 
 
TABLE 15
LIST OF KEY PATENTS IN CELL ISOLATION MARKET, 2023–2025
 
 
 
 
 
 
TABLE 16
CASE STUDIES OF AI IMPLEMENTATION IN CELL ISOLATION MARKET
 
 
 
 
 
 
TABLE 17
CLIENTS’ READINESS TO ADOPT AI-INTEGRATED CELL ISOLATION TECHNOLOGIES IN CELL ISOLATION MARKET
 
 
 
 
 
 
TABLE 18
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT
 
 
 
 
 
 
TABLE 19
KEY BUYING CRITERIA, BY END USER
 
 
 
 
 
 
TABLE 20
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 21
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 22
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 23
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 24
CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 25
CELL ISOLATION CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 26
NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 27
EUROPE: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 28
ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 29
LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 30
MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 31
GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 32
CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 33
CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 34
NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 35
EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 36
ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 37
LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 38
MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 39
GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 40
CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 41
CELL ISOLATION REAGENTS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 42
NORTH AMERICA: CELL ISOLATION REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 43
EUROPE: CELL ISOLATION REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 44
ASIA PACIFIC: CELL ISOLATION REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 45
LATIN AMERICA: CELL ISOLATION REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 46
MIDDLE EAST: CELL ISOLATION REAGENTS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 47
GCC COUNTRIES: CELL ISOLATION REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 48
TISSUE DISSOCIATION REAGENTS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 49
NORTH AMERICA: TISSUE DISSOCIATION REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 50
EUROPE: TISSUE DISSOCIATION REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 51
ASIA PACIFIC: TISSUE DISSOCIATION REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 52
LATIN AMERICA: TISSUE DISSOCIATION REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 53
MIDDLE EAST: TISSUE DISSOCIATION REAGENTS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 54
GCC COUNTRIES: TISSUE DISSOCIATION REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 55
OTHER REAGENTS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 56
NORTH AMERICA: OTHER REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 57
EUROPE: OTHER REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 58
ASIA PACIFIC: OTHER REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 59
LATIN AMERICA: OTHER REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 60
MIDDLE EAST: OTHER REAGENTS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 61
GCC COUNTRIES: OTHER REAGENTS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 62
CELL ISOLATION CONSUMABLES MARKET FOR MEDIA & SERA, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 63
NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR MEDIA & SERA, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 64
EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR MEDIA & SERA, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 65
ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR MEDIA & SERA, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 66
LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR MEDIA & SERA, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 67
MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET FOR MEDIA & SERA, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 68
GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET FOR MEDIA & SERA, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 69
CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 70
NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 71
EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 72
ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 73
LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 74
MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 75
GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 76
CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 77
NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 78
EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 79
ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 80
LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 81
MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 82
GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 83
CELL ISOLATION INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 84
NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 85
EUROPE: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 86
ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 87
LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 88
MIDDLE EAST: CELL ISOLATION INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 89
GCC COUNTRIES: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 90
CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 91
CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 92
NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 93
EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 94
ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 95
LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 96
MIDDLE EAST: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 97
GCC COUNTRIES: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 98
CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 99
NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 100
EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 101
ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 102
LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 103
MIDDLE EAST: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 104
GCC COUNTRIES: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 105
CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 106
NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 107
EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 108
ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 109
LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 110
MIDDLE EAST: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 111
GCC COUNTRIES: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 112
CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 113
NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 114
EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 115
ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 116
LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 117
MIDDLE EAST: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 118
GCC COUNTRIES: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 119
OTHER CELL ISOLATION INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 120
NORTH AMERICA: OTHER CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 121
EUROPE: OTHER CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 122
ASIA PACIFIC: OTHER CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 123
LATIN AMERICA: OTHER CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 124
MIDDLE EAST: OTHER CELL ISOLATION INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 125
GCC COUNTRIES: OTHER CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 126
CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 127
CELL ISOLATION MARKET FOR HUMAN CELLS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 128
NORTH AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 129
EUROPE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 130
ASIA PACIFIC: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 131
LATIN AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 132
MIDDLE EAST: CELL ISOLATION MARKET FOR HUMAN CELLS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 133
GCC COUNTRIES: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 134
CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 135
CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 136
NORTH AMERICA: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 137
EUROPE: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 138
ASIA PACIFIC: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 139
LATIN AMERICA: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 140
MIDDLE EAST: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 141
GCC COUNTRIES: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 142
CELL ISOLATION MARKET FOR STEM CELLS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 143
NORTH AMERICA: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 144
EUROPE: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 145
ASIA PACIFIC: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 146
LATIN AMERICA: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 147
MIDDLE EAST: CELL ISOLATION MARKET FOR STEM CELLS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 148
GCC COUNTRIES: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 149
CELL ISOLATION MARKET FOR ANIMAL CELLS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 150
NORTH AMERICA: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 151
EUROPE: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 152
ASIA PACIFIC: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 153
LATIN AMERICA: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 154
MIDDLE EAST: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 155
GCC COUNTRIES: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 156
CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 157
CELL ISOLATION MARKET FOR BLOOD & BLOOD-DERIVED SAMPLES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 158
NORTH AMERICA: CELL ISOLATION MARKET FOR BLOOD & BLOOD-DERIVED SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 159
EUROPE: CELL ISOLATION MARKET FOR BLOOD & BLOOD-DERIVED SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 160
ASIA PACIFIC: CELL ISOLATION MARKET FOR BLOOD & BLOOD-DERIVED SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 161
LATIN AMERICA: CELL ISOLATION MARKET FOR BLOOD & BLOOD-DERIVED SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 162
MIDDLE EAST: CELL ISOLATION MARKET FOR BLOOD & BLOOD-DERIVED SAMPLES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 163
GCC COUNTRIES: CELL ISOLATION MARKET FOR BLOOD & BLOOD-DERIVED SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 164
CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 165
NORTH AMERICA: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 166
EUROPE: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 167
ASIA PACIFIC: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 168
LATIN AMERICA: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 169
MIDDLE EAST: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 170
GCC COUNTRIES: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 171
CELL ISOLATION MARKET FOR BONE MARROW, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 172
NORTH AMERICA: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 173
EUROPE: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 174
ASIA PACIFIC: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 175
LATIN AMERICA: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 176
MIDDLE EAST: CELL ISOLATION MARKET FOR BONE MARROW, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 177
GCC COUNTRIES: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 178
CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 179
NORTH AMERICA: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 180
EUROPE: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 181
ASIA PACIFIC: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 182
LATIN AMERICA: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 183
MIDDLE EAST: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 184
GCC COUNTRIES: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 185
CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 186
NORTH AMERICA: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 187
EUROPE: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 188
ASIA PACIFIC: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 189
LATIN AMERICA: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 190
MIDDLE EAST: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 191
GCC COUNTRIES: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 192
CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 193
CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 194
NORTH AMERICA: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 195
EUROPE: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 196
ASIA PACIFIC: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 197
LATIN AMERICA: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 198
MIDDLE EAST: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 199
GCC COUNTRIES: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 200
SURFACE MARKER-BASED CELL ISOLATION MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 201
NORTH AMERICA: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 202
EUROPE: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 203
ASIA PACIFIC: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 204
LATIN AMERICA: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 205
MIDDLE EAST: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 206
GCC COUNTRIES: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 207
FILTRATION-BASED CELL ISOLATION MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 208
NORTH AMERICA: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 209
EUROPE: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 210
ASIA PACIFIC: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 211
LATIN AMERICA: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 212
MIDDLE EAST: FILTRATION-BASED CELL ISOLATION MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 213
GCC COUNTRIES: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 214
MICROFLUIDICS & LABEL-FREE CELL ISOLATION MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 215
NORTH AMERICA: MICROFLUIDICS & LABEL-FREE CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 216
EUROPE: MICROFLUIDICS & LABEL-FREE CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 217
ASIA PACIFIC: MICROFLUIDICS & LABEL-FREE CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 218
LATIN AMERICA: MICROFLUIDICS & LABEL-FREE CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 219
MIDDLE EAST: MICROFLUIDICS & LABEL-FREE CELL ISOLATION MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 220
GCC COUNTRIES: MICROFLUIDICS & LABEL-FREE CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 221
CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 222
CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 223
NORTH AMERICA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 224
EUROPE: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 225
ASIA PACIFIC: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 226
LATIN AMERICA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 227
MIDDLE EAST: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 228
GCC COUNTRIES: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 229
CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 230
CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 231
NORTH AMERICA: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 232
EUROPE: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 233
ASIA PACIFIC: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 234
LATIN AMERICA: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 235
MIDDLE EAST: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 236
GCC COUNTRIES: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 237
CELL ISOLATION MARKET FOR CANCER RESEARCH, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 238
NORTH AMERICA: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 239
EUROPE: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 240
ASIA PACIFIC: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 241
LATIN AMERICA: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 242
MIDDLE EAST: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 243
GCC COUNTRIES: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 244
CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 245
NORTH AMERICA: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 246
EUROPE: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 247
ASIA PACIFIC: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 248
LATIN AMERICA: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 249
MIDDLE EAST: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 250
GCC COUNTRIES: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 251
CELL ISOLATION MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 252
NORTH AMERICA: CELL ISOLATION MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 253
EUROPE: CELL ISOLATION MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 254
ASIA PACIFIC: CELL ISOLATION MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 255
LATIN AMERICA: CELL ISOLATION MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 256
MIDDLE EAST: CELL ISOLATION MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 257
GCC COUNTRIES: CELL ISOLATION MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 258
CELL ISOLATION MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 259
NORTH AMERICA: CELL ISOLATION MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 260
EUROPE: CELL ISOLATION MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 261
ASIA PACIFIC: CELL ISOLATION MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 262
LATIN AMERICA: CELL ISOLATION MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 263
MIDDLE EAST: CELL ISOLATION MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 264
GCC COUNTRIES: CELL ISOLATION MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 265
CELL ISOLATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 266
NORTH AMERICA: CELL ISOLATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 267
EUROPE: CELL ISOLATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 268
ASIA PACIFIC: CELL ISOLATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 269
LATIN AMERICA: CELL ISOLATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 270
MIDDLE EAST: CELL ISOLATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 271
GCC COUNTRIES: CELL ISOLATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 272
CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 273
NORTH AMERICA: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 274
EUROPE: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 275
ASIA PACIFIC: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 276
LATIN AMERICA: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 277
MIDDLE EAST: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 278
GCC COUNTRIES: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 279
CELL ISOLATION MARKET FOR CGT MANUFACTURING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 280
NORTH AMERICA: CELL ISOLATION MARKET FOR CGT MANUFACTURING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 281
EUROPE: CELL ISOLATION MARKET FOR CGT MANUFACTURING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 282
ASIA PACIFIC: CELL ISOLATION MARKET FOR CGT MANUFACTURING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 283
LATIN AMERICA: CELL ISOLATION MARKET FOR CGT MANUFACTURING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 284
MIDDLE EAST: CELL ISOLATION MARKET FOR CGT MANUFACTURING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 285
GCC COUNTRIES: CELL ISOLATION MARKET FOR CGT MANUFACTURING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 286
CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 287
CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 288
NORTH AMERICA: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 289
EUROPE: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 290
ASIA PACIFIC: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 291
LATIN AMERICA: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 292
MIDDLE EAST: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 293
GCC COUNTRIES: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 294
CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 295
NORTH AMERICA: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 296
EUROPE: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 297
ASIA PACIFIC: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 298
LATIN AMERICA: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 299
MIDDLE EAST: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 300
GCC COUNTRIES: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 301
CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 302
NORTH AMERICA: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 303
EUROPE: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 304
ASIA PACIFIC: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 305
LATIN AMERICA: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 306
MIDDLE EAST: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 307
GCC COUNTRIES: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 308
CELL ISOLATION MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 309
NORTH AMERICA: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 310
EUROPE: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 311
ASIA PACIFIC: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 312
LATIN AMERICA: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 313
MIDDLE EAST: CELL ISOLATION MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 314
GCC COUNTRIES: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 315
CELL ISOLATION MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 316
NORTH AMERICA: CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 317
NORTH AMERICA: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 318
NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 319
NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 320
NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 321
NORTH AMERICA: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 322
NORTH AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 323
NORTH AMERICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 324
NORTH AMERICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 325
NORTH AMERICA: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 326
NORTH AMERICA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 327
NORTH AMERICA: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 328
US: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 329
US: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 330
US: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 331
US: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 332
US: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 333
US: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 334
US: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 335
US: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 336
US: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 337
US: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 338
US: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 339
CANADA: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 340
CANADA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 341
CANADA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 342
CANADA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 343
CANADA: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 344
CANADA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 345
CANADA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 346
CANADA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 347
CANADA: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 348
CANADA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 349
CANADA: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 350
EUROPE: CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 351
EUROPE: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 352
EUROPE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 353
EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 354
EUROPE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 355
EUROPE: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 356
EUROPE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 357
EUROPE: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 358
EUROPE: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 359
EUROPE: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 360
EUROPE: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 361
EUROPE: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 362
GERMANY: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 363
GERMANY: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 364
GERMANY: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 365
GERMANY: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 366
GERMANY: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 367
GERMANY: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 368
GERMANY: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 369
GERMANY: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 370
GERMANY: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 371
GERMANY: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 372
GERMANY: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 373
UK: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 374
UK: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 375
UK: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 376
UK: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 377
UK: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 378
UK: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 379
UK: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 380
UK: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 381
UK: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 382
UK: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 383
UK: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 384
FRANCE: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 385
FRANCE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 386
FRANCE: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 387
FRANCE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 388
FRANCE: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 389
FRANCE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 390
FRANCE: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 391
FRANCE: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 392
FRANCE: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 393
FRANCE: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 394
FRANCE: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 395
ITALY: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 396
ITALY: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 397
ITALY: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 398
ITALY: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 399
ITALY: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 400
ITALY: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 401
ITALY: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 402
ITALY: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 403
ITALY: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 404
ITALY: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 405
ITALY: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 406
SPAIN: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 407
SPAIN: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 408
SPAIN: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 409
SPAIN: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 410
SPAIN: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 411
SPAIN: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 412
SPAIN: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 413
SPAIN: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 414
SPAIN: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 415
SPAIN: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 416
SPAIN: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 417
REST OF EUROPE: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 418
REST OF EUROPE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 419
REST OF EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 420
REST OF EUROPE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 421
REST OF EUROPE: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 422
REST OF EUROPE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 423
REST OF EUROPE: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 424
REST OF EUROPE: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 425
REST OF EUROPE: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 426
REST OF EUROPE: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 427
REST OF EUROPE: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 428
ASIA PACIFIC: CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 429
ASIA PACIFIC: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 430
ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 431
ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 432
ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 433
ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 434
ASIA PACIFIC: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 435
ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 436
ASIA PACIFIC: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 437
ASIA PACIFIC: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 438
ASIA PACIFIC: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 439
ASIA PACIFIC: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 440
CHINA: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 441
CHINA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 442
CHINA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 443
CHINA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 444
CHINA: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 445
CHINA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 446
CHINA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 447
CHINA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 448
CHINA: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 449
CHINA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 450
CHINA: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 451
JAPAN: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 452
JAPAN: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 453
JAPAN: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 454
JAPAN: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 455
JAPAN: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 456
JAPAN: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 457
JAPAN: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 458
JAPAN: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 459
JAPAN: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 460
JAPAN: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 461
JAPAN: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 462
INDIA: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 463
INDIA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 464
INDIA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 465
INDIA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 466
INDIA: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 467
INDIA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 468
INDIA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 469
INDIA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 470
INDIA: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 471
INDIA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 472
INDIA: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 473
AUSTRALIA: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 474
AUSTRALIA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 475
AUSTRALIA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 476
AUSTRALIA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 477
AUSTRALIA: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 478
AUSTRALIA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 479
AUSTRALIA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 480
AUSTRALIA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 481
AUSTRALIA: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 482
AUSTRALIA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 483
AUSTRALIA: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 484
SOUTH KOREA: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 485
SOUTH KOREA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 486
SOUTH KOREA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 487
SOUTH KOREA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 488
SOUTH KOREA: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 489
SOUTH KOREA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 490
SOUTH KOREA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 491
SOUTH KOREA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 492
SOUTH KOREA: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 493
SOUTH KOREA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 494
SOUTH KOREA: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 495
REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 496
REST OF ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 497
REST OF ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 498
REST OF ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 499
REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 500
REST OF ASIA PACIFIC: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 501
REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 502
REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 503
REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 504
REST OF ASIA PACIFIC: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 505
REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 506
LATIN AMERICA: CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 507
LATIN AMERICA: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 508
LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 509
LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 510
LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 511
LATIN AMERICA: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 512
LATIN AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 513
LATIN AMERICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 514
LATIN AMERICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 515
LATIN AMERICA: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 516
LATIN AMERICA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 517
LATIN AMERICA: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 518
BRAZIL: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 519
BRAZIL: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 520
BRAZIL: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 521
BRAZIL: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 522
BRAZIL: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 523
BRAZIL: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 524
BRAZIL: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 525
BRAZIL: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 526
BRAZIL: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 527
BRAZIL: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 528
BRAZIL: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 529
MEXICO: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 530
MEXICO: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 531
MEXICO: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 532
MEXICO: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 533
MEXICO: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 534
MEXICO: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 535
MEXICO: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 536
MEXICO: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 537
MEXICO: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 538
MEXICO: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 539
MEXICO: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 540
REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 541
REST OF LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 542
REST OF LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 543
REST OF LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 544
REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 545
REST OF LATIN AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 546
REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 547
REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 548
REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 549
REST OF LATIN AMERICA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 550
REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 551
MIDDLE EAST: CELL ISOLATION MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 552
MIDDLE EAST: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 553
MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 554
MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 555
MIDDLE EAST: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 556
MIDDLE EAST: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 557
MIDDLE EAST: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 558
MIDDLE EAST: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 559
MIDDLE EAST: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 560
MIDDLE EAST: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 561
MIDDLE EAST: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 562
MIDDLE EAST: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 563
GCC COUNTRIES: CELL ISOLATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 564
GCC COUNTRIES: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 565
GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 566
GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 567
GCC COUNTRIES: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 568
GCC COUNTRIES: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 569
GCC COUNTRIES: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 570
GCC COUNTRIES: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 571
GCC COUNTRIES: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 572
GCC COUNTRIES: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 573
GCC COUNTRIES: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 574
GCC COUNTRIES: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 575
SAUDI ARABIA: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 576
SAUDI ARABIA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 577
SAUDI ARABIA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 578
SAUDI ARABIA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 579
SAUDI ARABIA: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 580
SAUDI ARABIA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 581
SAUDI ARABIA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 582
SAUDI ARABIA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 583
SAUDI ARABIA: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 584
SAUDI ARABIA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 585
SAUDI ARABIA: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 586
UAE: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 587
UAE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 588
UAE: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 589
UAE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 590
UAE: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 591
UAE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 592
UAE: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 593
UAE: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 594
UAE: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 595
UAE: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 596
UAE: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 597
REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 598
REST OF GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 599
REST OF GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 600
REST OF GCC COUNTRIES: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 601
REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 602
REST OF GCC COUNTRIES: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 603
REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 604
REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 605
REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 606
REST OF GCC COUNTRIES: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 607
REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 608
REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 609
REST OF MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 610
REST OF MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 611
REST OF MIDDLE EAST: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 612
REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 613
REST OF MIDDLE EAST: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 614
REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 615
REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 616
REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 617
REST OF MIDDLE EAST: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 618
REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 619
AFRICA: CELL ISOLATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 620
AFRICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 621
AFRICA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 622
AFRICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 623
AFRICA: CELL ISOLATION MARKET, BY CELL TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 624
AFRICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 625
AFRICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 626
AFRICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 627
AFRICA: CELL ISOLATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 628
AFRICA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 629
AFRICA: CELL ISOLATION MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 630
OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN CELL ISOLATION MARKET, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 631
CELL ISOLATION MARKET: DEGREE OF COMPETITION
 
 
 
 
 
 
TABLE 632
CELL ISOLATION MARKET: REGION FOOTPRINT
 
 
 
 
 
 
TABLE 633
CELL ISOLATION MARKET: PRODUCT FOOTPRINT
 
 
 
 
 
 
TABLE 634
CELL ISOLATION MARKET: CELL TYPE FOOTPRINT
 
 
 
 
 
 
TABLE 635
CELL ISOLATION MARKET: END-USER FOOTPRINT
 
 
 
 
 
 
TABLE 636
CELL ISOLATION MARKET: DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
 
 
TABLE 637
CELL ISOLATION MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
 
 
 
 
TABLE 638
CELL ISOLATION MARKET: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 639
CELL ISOLATION MARKET: DEALS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 640
CELL ISOLATION MARKET: EXPANSIONS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 641
DANAHER CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 642
DANAHER CORPORATION: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 643
DANAHER CORPORATION: DEALS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 644
MERCK KGAA: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 645
MERCK KGAA: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 646
MERCK KGAA: DEALS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 647
MERCK KGAA: EXPANSIONS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 648
THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 649
THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 650
THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 651
THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 652
THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 653
BD: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 654
BD: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 655
BD: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 656
BD: DEALS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 657
AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 658
AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 659
AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 660
SARTORIUS AG: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 661
SARTORIUS AG: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 662
BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 663
BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 664
BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 665
QIAGEN: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 666
QIAGEN: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 667
QIAGEN: DEALS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 668
F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 669
F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 670
F. HOFFMANN-LA ROCHE LTD.: EXPANSIONS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 671
REVVITY: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 672
REVVITY: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 673
CORNING INCORPORATED: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 674
CORNING INCORPORATED: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 675
LONZA: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 676
LONZA: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 677
BIO-TECHNE: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 678
BIO-TECHNE: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 679
TERUMO CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 680
TERUMO CORPORATION: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 681
MILTENYI BIOTEC: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 682
MILTENYI BIOTEC: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 683
TAKARA BIO INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 684
TAKARA BIO INC.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 685
GENSCRIPT: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 686
GENSCRIPT: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 687
GENSCRIPT: DEALS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 688
SONY CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 689
SONY CORPORATION: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 690
ALFA LAVAL: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 691
ALFA LAVAL: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 692
ALFA LAVAL: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 693
ALFA LAVAL: DEALS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 694
PROMEGA CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 695
CELL SIGNALING TECHNOLOGY, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 696
MICAREO INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 697
APPLIED CELLS, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 698
STEMCELL TECHNOLOGIES: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 699
CREATIVE BIOARRAY: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 700
PROTEINTECH GROUP, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 701
MAGBIO GENOMICS, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 702
AKADEUM LIFE SCIENCES: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 703
PLURISELECT LIFE SCIENCE UG (HAFTUNGSBESCHRÄNKT) & CO. KG: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 704
INVENT BIOTECHNOLOGIES, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 705
IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
 
 
 
 
 
 
TABLE 706
RISK ASSESSMENT
 
 
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
 
 
FIGURE 1
CELL ISOLATION MARKET SEGMENTATION & REGIONS CONSIDERED
 
 
 
 
 
 
FIGURE 2
CELL ISOLATION MARKET: YEARS CONSIDERED
 
 
 
 
 
 
FIGURE 3
MARKET SCENARIO
 
 
 
 
 
 
FIGURE 4
GLOBAL CELL ISOLATION MARKET, 2024–2031
 
 
 
 
 
 
FIGURE 5
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN CELL ISOLATION MARKET, 2023–2026
 
 
 
 
 
 
FIGURE 6
DISRUPTIONS INFLUENCING GROWTH OF CELL ISOLATION MARKET
 
 
 
 
 
 
FIGURE 7
HIGH-GROWTH SEGMENTS IN CELL ISOLATION MARKET, 2026–2031
 
 
 
 
 
 
FIGURE 8
ASIA PACIFIC TO REGISTER HIGHEST CAGR IN CELL ISOLATION MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 9
RISING ADOPTION OF STEM CELL RESEARCH AND IMMUNOLOGY RESEARCH TO DRIVE MARKET GROWTH
 
 
 
 
 
 
FIGURE 10
CONSUMABLES ACCOUNTED FOR LARGEST SHARE OF CELL ISOLATION MARKET IN NORTH AMERICA IN 2025
 
 
 
 
 
 
FIGURE 11
ASIA PACIFIC IS LIKELY TO BE FASTEST-GROWING MARKET IN GLOBAL CELL ISOLATION MARKET DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 12
CONSUMABLES TO DOMINATE MARKET DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 13
CELL ISOLATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
 
 
FIGURE 14
CELL ISOLATION MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
FIGURE 15
CELL ISOLATION MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
 
 
FIGURE 16
CELL ISOLATION MARKET: ECOSYSTEM ANALYSIS
 
 
 
 
 
 
FIGURE 17
AVERAGE SELLING PRICE OF CELL ISOLATION INSTRUMENTS, BY KEY PLAYER, 2025 (USD)
 
 
 
 
 
 
FIGURE 18
AVERAGE SELLING PRICE OF CELL ISOLATION CONSUMABLES, BY KEY PLAYER, 2025 (USD)
 
 
 
 
 
 
FIGURE 19
AVERAGE SELLING PRICE OF CELL ISOLATION INSTRUMENTS, BY REGION, 2025 (USD)
 
 
 
 
 
 
FIGURE 20
AVERAGE SELLING PRICE OF CELL ISOLATION CONSUMABLES, BY REGION, 2025 (USD)
 
 
 
 
 
 
FIGURE 21
CELL ISOLATION MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
 
 
 
 
 
 
FIGURE 22
INVESTMENT & FUNDING SCENARIO, 2023–2025 (USD MILLION)
 
 
 
 
 
 
FIGURE 23
PATENT APPLICATIONS IN CELL ISOLATION MARKET, JANUARY 2015–DECEMBER 2025
 
 
 
 
 
 
FIGURE 24
IMPACT OF AI/GEN AI ON CELL ISOLATION MARKET
 
 
 
 
 
 
FIGURE 25
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT
 
 
 
 
 
 
FIGURE 26
KEY BUYING CRITERIA, BY END USER
 
 
 
 
 
 
FIGURE 27
NORTH AMERICA: CELL ISOLATION MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 28
ASIA PACIFIC: CELL ISOLATION MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 29
REVENUE ANALYSIS OF KEY PLAYERS IN CELL ISOLATION MARKET, 2021–2025 (USD MILLION)
 
 
 
 
 
 
FIGURE 30
MARKET SHARE ANALYSIS OF KEY PLAYERS IN CELL ISOLATION MARKET, 2025
 
 
 
 
 
 
FIGURE 31
CELL ISOLATION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
 
 
 
 
 
 
FIGURE 32
CELL ISOLATION MARKET: COMPANY FOOTPRINT
 
 
 
 
 
 
FIGURE 33
CELL ISOLATION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
 
 
 
 
 
 
FIGURE 34
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
 
 
 
 
 
 
FIGURE 35
EV/EBITDA OF KEY VENDORS
 
 
 
 
 
 
FIGURE 36
CELL ISOLATION MARKET: BRAND COMPARISON
 
 
 
 
 
 
FIGURE 37
DANAHER CORPORATION: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 38
MERCK KGAA: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 39
THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 40
BD: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 41
AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 42
SARTORIUS AG: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 43
BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 44
QIAGEN: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 45
F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 46
REVVITY: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 47
CORNING INCORPORATED: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 48
LONZA: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 49
BIO-TECHNE: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 50
TERUMO CORPORATION: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 51
TAKARA BIO INC.: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 52
GENSCRIPT: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 53
SONY CORPORATION: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 54
ALFA LAVAL: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 55
CELL ISOLATION MARKET: RESEARCH DESIGN
 
 
 
 
 
 
FIGURE 56
CELL ISOLATION MARKET: BREAKDOWN OF PRIMARIES
 
 
 
 
 
 
FIGURE 57
CELL ISOLATION MARKET: INSIGHTS FROM PRIMARIES
 
 
 
 
 
 
FIGURE 58
GLOBAL CELL ISOLATION MARKET ESTIMATION, 2025
 
 
 
 
 
 
FIGURE 59
CELL ISOLATION MARKET: COMPANY REVENUE ANALYSIS-BASED ESTIMATION (BOTTOM-UP APPROACH) (2025)
 
 
 
 
 
 
FIGURE 60
ILLUSTRATIVE EXAMPLE OF DANAHER CORPORATION: REVENUE ANALYSIS (2025)
 
 
 
 
 
 
FIGURE 61
SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
 
 
 
 
 
 
FIGURE 62
CELL ISOLATION MARKET: CAGR PROJECTIONS
 
 
 
 
 
 
FIGURE 63
CELL ISOLATION MARKET: DATA TRIANGULATION
 
 
 
 
 
 

Methodology

This research study extensively used secondary sources, directories, and databases to identify and collect information for analysis of the global cell isolation market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was triangulated with primary research inputs to determine the final market size.

Secondary Research

Secondary research was primarily used to identify and collect information for the comprehensive technical, market-oriented, and commercial study of the cell isolation market. The secondary sources used for this study include World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), National Center for Biotechnology Information (NCBI), Stem Cell Society Singapore (SCSS), International Society for Advancement of Cytometry (ISAC), American Filtration and Separations Society (AFS), Food and Drug Administration (FDA), American Society for Cell Biology (ASC8), National Institutes of Health (NIH), International Society for Cell & Gene Therapy (ISCT), American Society for Gene and Cell Therapy (ASGCT), Pharmaceutical Research and Manufacturers of America (PhRMA), Japan Agency for Medical Research and Development, European Federation of Pharmaceutical Industries and Associations (EFPIA), and the Alliance for Regenerative Medicine (ARM). Secondary data were collected and analyzed to determine the overall size of the global cell isolation market, which was subsequently validated through primary research. These sources were also used to gather key information about major players, market classification, and segmentation based on industry trends, regional/country-level markets, market developments, and technological perspectives.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market’s prospects. Various primary sources from the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information.

Data Center Storage Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The top-down and bottom-up approaches were used to estimate & validate the total size of the cell isolation market. These methods were also used extensively to estimate the size of various market segments.

Cell Isolation Market/Cell Separation Market : Top-Down and Bottom-Up Approach

Cell Isolation Market/Cell Separation Market Top Down and Bottom Up Approach

Data Triangulation

After evaluating the overall market size through the market size estimation process, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were used, whenever applicable, to complete the overall market engineering process and obtain precise statistics for all segments and subsegments. The data was triangulated by analyzing various factors and trends from the demand and supply sides.

Market Definition

Cell isolation is the process of separating specific cells from a given sample. It is a tool in biological research that enables the isolation of a single cell type from heterogeneous cell populations without contamination by other cell types. This process is widely used for the isolation of biomolecules to produce vaccines, drugs, antibodies, enzymes, proteins, and other biotechnology products.

Key Stakeholders

  • Pharmaceutical & biotechnology companies
  • Contract research organizations (CROs)
  • Life science companies
  • Academic & research institutes
  • Private research institutes
  • Venture capitalists & investors
  • Hospitals and diagnostic laboratories
  • Market research & consulting firms
  • Medical institutions & universities

Report Objectives

  • To define, describe, and forecast the cell isolation market based on product, cell type, cell source, technique, application, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall cell isolation market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments concerning six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
  • To strategically profile the key players in the cell isolation market and comprehensively analyze their core competencies and market rankings
  • To track and analyze competitive developments such as product launches, acquisitions, expansions, agreements, partnerships, and collaborations in the cell isolation market
  • To benchmark players within the cell isolation market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business and product/service strategy

Customization Options :

With the given market data, MarketsandMarkets offers customizations per the company’s specific needs. The following customization options are available for this report:

Geographical Analysis

  • Further breakdown of the Rest of Europe Cell Isolation Market, by country
  • Further breakdown of the Rest of Asia Pacific Cell Isolation Market, by country
  • Further breakdown of the Rest of Latin America Cell Isolation Market, by country
  • Further breakdown of the Rest of Middle East Cell Isolation Market, by country

Company Information

  • Detailed analysis and profiling of additional market players (up to five)

TABLE OF CONTENTS

METHODOLOGY

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
Cite this Research

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Cell Isolation Market/ Cell Separation Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request
Forbes

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

TESTIMONIALS

Growth opportunities and latent adjacency in Cell Isolation Market/ Cell Separation Market

DMCA.com Protection Status